Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 5

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
  
     118,898 
  
    Stock based compensation expense - issuance of common stock for services rendered 
     -  
     33,450 
  
    Amortization of financing costs 
     -  
     9,456 
  
    Accretion of unearned loan discount 
     -  
     88,970 
  
    Accretion of loan premium 
     -  
     20,606 
  
    Non-cash lease expense from right-of-use assets 
     18,253  
     15,949 
  
    Change in fair value of derivative liabilities 
     -  
     (2,517)
  
    Changes in operating assets and liabilities: 

    Grant receivable 
     1,924,246  
     - 
  
    Prepaid and other current assets 
     176,013  
     76,712 
  
    Accounts payable and accrued expenses 
     (633,956) 
     (133,940)
  
    Operating lease liabilities 
     (17,164) 
     (13,843)
  
    Net cash used in operating activities 
     (3,023,874) 
     (3,579,456)

    CASH FLOWS FROM INVESTING ACTIVITIES: 

    Net cash provided by investing activities 
     -  
     - 

    CASH FLOWS FROM FINANCING ACTIVITIES: 

    Net proceeds from issuance of common stock 
     10,457,629  
     2,259,063 
  
    Payment of loan premium 
     -  
     (2,500,000)
  
    Net cash provided by (used in) financing activities 
     10,457,629  
     (240,937)

    Net change in cash and cash equivalents 
     7,433,755  
     (3,820,393)

    Cash and cash equivalents, beginning of period 
     17,544,547  
     23,843,798 

    Cash and cash equivalents, end of period 
    $24,978,302  
    $20,023,405 

    SUPPLEMENTAL CASH FLOW INFORMATION: 

    Cash paid for interest 
    $-  
    $136,992 

    SUPPLEMENTAL DISC